SBV Journal of Basic, Clinical and Applied Health Science

Register      Login

VOLUME 2 , ISSUE 4 ( October-December, 2019 ) > List of Articles

CASE REPORT

Fluoxetine-induced Kleptomania in a Patient with Depressive Disorder: A Case Report

Melody M Annamalai, Avudaiappan Sankaran, Sukanto Sarkar

Keywords : Kleptomania, Selective serotonin receptor inhibitors,Depression

Citation Information : Annamalai MM, Sankaran A, Sarkar S. Fluoxetine-induced Kleptomania in a Patient with Depressive Disorder: A Case Report. 2019; 2 (4):156-157.

DOI: 10.5005/jp-journals-10082-02229

License: CC BY-NC 4.0

Published Online: 15-07-2020

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Kleptomania is a disorder wherein the individual has an irresistible urge/impulse to steal things that are usually not of monetary value. Selective serotonin receptor inhibitors (SSRIs) are usually the first-line treatment of depressive disorders. Reports of depressed patients experiencing symptoms of kleptomania after administration of SSRI have been few. Here we present such a case of a female patient who exhibited symptoms of kleptomania following treatment with fluoxetine, an SSRI.


PDF Share
  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed., Washington, D.C: American Psychiatric Association; 2013. p. 947.
  2. Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. 11th ed., Philadelphia: Wolters Kluwer; 2015. p. 1472.
  3. McElroy SL, Hudson JI, Pope HG, Keck PE. Kleptomania: clinical characteristics and associated psychopathology. Psychol Med 1991;21(1):93–108. DOI: 10.1017/s0033291700014690.
  4. Grant JE, Kim SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry 2002;43(5):378–384. DOI: 10.1053/comp.2002.34628.
  5. Kindler S, Dannon PN, Iancu I, Sasson Y, Zohar J. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. Clin Neuropharmacol 1997;20(2): 126–129. DOI: 10.1097/00002826-199704000-00003.
  6. Gupta PR. Emergence of kleptomania during treatment for obsessive compulsive disorder with fluvoxamine. Indian J Psychiatry 2014;56(1):100–101. DOI: 10.4103/0019-5545.124741.
  7. Mangot AG. Kleptomania: beyond serotonin. J Neurosci Rural Pract 2014;5(Suppl 1):S105–S106. DOI: 10.4103/0976-3147.145244.
  8. Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 2007;113(2):296–320. DOI: 10.1016/j.pharmthera.2006.08.004.
  9. Lepkifker E, Dannon PN, Ziv R, Iancu I, Horesh N, Kotler M. The treatment of kleptomania with serotonin reuptake inhibitors. Clin Neuropharmacol 1999;22(1):40–43. DOI: 10.1097/00002826-199901000-00008.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.